- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
GALNT7 Antibody / O-Glycosylation Enzyme Antibody detects GALNT7, a member of the polypeptide N-acetylgalactosaminyltransferase family that initiates mucin-type O-linked glycosylation. GALNT7 catalyzes the transfer of N-acetylgalactosamine from UDP-N-acetylgalactosamine to serine and threonine residues on target proteins, generating the first carbohydrate modification required for O-glycan biosynthesis. This essential post-translational modification regulates protein stability, trafficking, protease resistance and cell surface interactions. GALNT7 Antibody / O-Glycosylation Enzyme Antibody is widely used to investigate protein glycosylation, epithelial biology and disease-associated changes in glycan synthesis.
GALNT7 is primarily localized within the Golgi apparatus, where it participates in the highly coordinated process of protein glycosylation before proteins are transported to the cell surface or secreted into the extracellular environment. Although multiple GALNT family members exhibit overlapping substrate specificities, GALNT7 displays unique preferences for particular peptide sequences and contributes to tissue-specific glycosylation patterns. Proper GALNT7 activity is important for the maturation of membrane proteins, receptors, adhesion molecules and mucins that regulate cellular communication and epithelial integrity. Consequently, GALNT7 Antibody / O-Glycosylation Enzyme Antibody provides an important tool for studying Golgi biology and post-translational protein processing.
Abnormal GALNT7 expression or activity has been associated with numerous human diseases, particularly cancer. Altered O-glycosylation can influence tumor cell proliferation, migration, invasion and immune evasion by modifying the structure and function of cell surface glycoproteins. Increased GALNT7 expression has been reported in several malignancies, including colorectal, cervical, ovarian and liver cancers, where it may contribute to tumor progression through dysregulated glycosylation pathways. Because changes in glycan composition frequently accompany malignant transformation, GALNT7 has become an important biomarker for investigations into cancer biology and therapeutic targeting.
Beyond oncology, GALNT7 contributes to normal developmental processes, epithelial homeostasis and regulation of secreted glycoproteins. The enzyme influences numerous biological pathways by modifying proteins involved in cell adhesion, signal transduction and receptor function. As interest in glycobiology continues to expand, understanding the individual roles of specific GALNT enzymes has become increasingly important for defining how O-linked glycosylation shapes cellular behavior in both health and disease.
NSJ Bioreagents offers GALNT7 Antibody / O-Glycosylation Enzyme Antibody products for researchers studying protein glycosylation, Golgi function, epithelial biology and cancer progression. These antibodies support applications including Western blot, immunohistochemistry, immunofluorescence and flow cytometry for analysis of GALNT7 expression and localization. GALNT7 Antibody / O-Glycosylation Enzyme Antibody provides a valuable tool for investigating mucin-type O-glycosylation, glycoprotein biosynthesis and disease-associated alterations in post-translational protein modification.
Researchers studying protein glycosylation and tumor biology may also be interested in our Cancer Antibodies page, featuring antibodies against glycosyltransferases, signaling proteins and other biomarkers involved in cancer progression, epithelial biology and therapeutic research.
Optimal dilution of the GALNT7 Antibody / O-Glycosylation Enzyme Antibody should be determined by the researcher.
E.coli-derived human GALNT7 recombinant protein (Position: K67-V657) was used as the immunogen for the GALNT7 antibody.
After reconstitution, the GALNT7 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
GalNAc-T7 antibody, Polypeptide N-Acetylgalactosaminyltransferase 7 antibody, UDP-N-Acetyl-alpha-D-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase 7 antibody, Protein GalNAc Transferase 7 antibody, ppGalNAc-T7 antibody, GALNAC-T7 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.